The primary objective was To guage the efficacy from the vaccine compared to placebo in reducing cocaine use. Secondary goals provided confirming vaccine immunogenicity through IgG anti-cocaine antibody amounts and evaluating the protection and tolerability of vaccination by way of a 20 week analyze and at 24 week abide by-up. https://annef307ppn3.techionblog.com/profile